Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study. Biomol Biomed. 2024;24(6):1776–1784. doi:10.17305/bb.2024.10512